Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page.

Non-Small Cell Lung Cancer

Lung cancer is the second most commonly diagnosed cancer in both men and women in the United States and the leading cause of all cancer deaths. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.1

What is lung cancer and how many people does it impact?

  • Lung cancer is the uncontrolled growth of cancerous cells originating in the lungs.1
  • In 2019, about 228,000 Americans are estimated to be diagnosed with lung cancer, and approximately 142,600 are projected to die from the disease.2
  • It is estimated that nearly 85 percent of lung cancer diagnoses are made when the disease is in the advanced stages.3